Establishes fetal and infant mortality review boards to study fetal and infant mortality and morbidity and make recommendations on policies, best practices, and strategies to reduce fetal and infant mortality and morbidity.
Impact
The bill's implementation will introduce formal structures for systematically reviewing fetal and infant death cases and severe morbidity incidents. It intends to address the significant impact of social determinants on health, such as racial and economic disparities, by creating policies and strategies to reduce the rates of infant and fetal loss. This proactive approach in public health legislation can lead to an enhancement in the overall quality of healthcare services provided to expectant mothers and infants, ensuring diversity in representation on the review boards to adequately reflect the populations affected.
Summary
Bill A05534, introduced to the New York Assembly, seeks to establish fetal and infant mortality review boards at both state and city levels to investigate and analyze the causes behind fetal and infant mortality and morbidity. The purpose of these boards is to gather detailed findings and develop actionable recommendations aimed at preventing such tragic outcomes. It empowers the state board to review cases and to provide guidance on best practices to improve fetal and infant health care throughout New York, particularly focusing on identified disparities in health outcomes among various demographic groups.
Contention
Support for Bill A05534 hinges on the necessity of addressing the alarming rates of fetal and infant mortality and the demand for improved health care responses to these issues. Critics may raise concerns about the board’s access to sensitive personal data and the potential implications surrounding confidentiality. However, the bill includes stringent measures to safeguard individual privacy, stipulating that any information reviewed remains confidential and protected from use in legal contexts, effectively mitigating concerns regarding data misuse.
Same As
Establishes fetal and infant mortality review boards to study fetal and infant mortality and morbidity and make recommendations on policies, best practices, and strategies to reduce fetal and infant mortality and morbidity.
Establishes fetal and infant mortality review boards to study fetal and infant mortality and morbidity and make recommendations on policies, best practices, and strategies to reduce fetal and infant mortality and morbidity.
Requires maternal mortality review boards to annually share information with the New York city and county health departments, including circumstances, common factors and patterns, best practices and strategies, primary data, vital records data, and any other guidance associated with reported cases of maternal mortality and morbidity.
Relating to the confidentiality and reporting of certain maternal mortality information to the Department of State Health Services, to an exception to certain reporting requirements for health care providers reviewing certain information on maternal mortality and morbidity, to the reimbursement of travel expenses incurred by Texas Maternal Mortality and Morbidity Review Committee members, and to a work group establishing a maternal mortality and morbidity data registry.